| Neuropsychiatric symptoms in untreated Parkinson’s disease S Szatmari, BMW Illigens, T Siepmann, A Pinter, A Takats, D Bereczki Neuropsychiatric disease and treatment, 815-826, 2017 | 55 | 2017 |
| Cardiac dysautonomia in depression–heart rate variability biofeedback as a potential add-on therapy A Pinter, S Szatmari Jr, T Horvath, AI Penzlin, K Barlinn, M Siepmann, ... Neuropsychiatric disease and treatment, 1287-1310, 2019 | 53 | 2019 |
| Association of restless legs syndrome with incident Parkinson’s disease S Szatmari Jr, D Bereczki, K Fornadi, K Kalantar-Zadeh, CP Kovesdy, ... Sleep 40 (2), zsw065, 2017 | 37 | 2017 |
| Linking Individual Patient Data to Estimate Incidence and Prevalence of Parkinson's Disease by Comparing Reports of Neurological Services and Pharmacy Prescription Refills at a … S Szatmári Jr, A Ajtay, M Bálint, A Takáts, F Oberfrank, D Bereczki Frontiers in Neurology 10, 2019 | 20 | 2019 |
| Cutaneous autonomic pilomotor testing to unveil the role of neuropathy progression in early Parkinson’s disease (CAPTURE PD): Protocol for a multicenter study T Siepmann, A Pintér, SJ Buchmann, L Stibal, M Arndt, AS Kubasch, ... Frontiers in Neurology 8, 212, 2017 | 14 | 2017 |
| The prevalence of psychiatric symptoms before the diagnosis of Parkinson’s disease in a nationwide cohort: A comparison to patients with cerebral infarction S Szatmári Jr, A Ajtay, F Oberfrank, B Dobi, D Bereczki PLoS One 15 (8), e0236728, 2020 | 12 | 2020 |
| Two‐Year observational study of autonomic skin function in patients with Parkinson's disease compared to healthy individuals T Siepmann, M Arndt, A Sedghi, S Szatmári Jr, T Horváth, A Takáts, ... European Journal of Neurology 30 (5), 1281-1292, 2023 | 4 | 2023 |
